Literature DB >> 24764651

Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma.

Bhavna Rani1, Yuan Cao1, Andrea Malfettone1, Ciprian Tomuleasa1, Isabel Fabregat1, Gianluigi Giannelli1.   

Abstract

Hepatocellular carcinoma is difficult to treat, primarily because the underlying molecular mechanisms driving clinical outcome are still poorly understood. Growing evidence suggests that the tissue microenvironment has a role in the biological behavior of the tumor. The main clinical issue is to identify the best target for therapeutic approaches. Here, we discuss the hypothesis that the entire tissue microenvironment might be considered as a biological target. However, the tissue microenvironment consists of several cellular and biochemical components, each of which displays a distinct biological activity. We discuss the major components of this environment and consider how they may interact to promote tumor/host crosstalk.

Entities:  

Keywords:  Cancer stem cells; Hepatocellular carcinoma; Laminin-5; Target therapy; Therapy; Tissue microenvironment; Transforming growth factor-beta

Mesh:

Substances:

Year:  2014        PMID: 24764651      PMCID: PMC3989949          DOI: 10.3748/wjg.v20.i15.4128

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  107 in total

Review 1.  Macrophage diversity enhances tumor progression and metastasis.

Authors:  Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

Review 2.  Stromal cells and integrins: conforming to the needs of the tumor microenvironment.

Authors:  Aimee Alphonso; Suresh K Alahari
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

3.  Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects.

Authors:  Wei Zhang; Xiao-Dong Zhu; Hui-Chuan Sun; Yu-Quan Xiong; Peng-Yuan Zhuang; Hua-Xiang Xu; Ling-Qun Kong; Lu Wang; Wei-Zhong Wu; Zhao-You Tang
Journal:  Clin Cancer Res       Date:  2010-06-22       Impact factor: 12.531

Review 4.  Hallmarks of cancer: interactions with the tumor stroma.

Authors:  Kristian Pietras; Arne Ostman
Journal:  Exp Cell Res       Date:  2010-03-06       Impact factor: 3.905

Review 5.  TGFbeta signalling: a complex web in cancer progression.

Authors:  Hiroaki Ikushima; Kohei Miyazono
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

6.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

Authors:  Neta Erez; Morgan Truitt; Peter Olson; Sarah Tuttleton Arron; Douglas Hanahan
Journal:  Cancer Cell       Date:  2010-02-04       Impact factor: 31.743

7.  The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines.

Authors:  Brigette B Y Ma; Fion Sung; Qian Tao; Fan Fong Poon; Vivian W Lui; Winnie Yeo; Stephen L Chan; Anthony T C Chan
Journal:  Invest New Drugs       Date:  2009-01-27       Impact factor: 3.850

8.  Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells.

Authors:  Dong-Ming Kuang; Chen Peng; Qiyi Zhao; Yan Wu; Min-Shan Chen; Limin Zheng
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

9.  Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma.

Authors:  Antonio Mazzocca; Emilia Fransvea; Francesco Dituri; Luigi Lupo; Salvatore Antonaci; Gianluigi Giannelli
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

Review 10.  Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms.

Authors:  Samuel Schmidt; Peter Friedl
Journal:  Cell Tissue Res       Date:  2009-11-17       Impact factor: 5.249

View more
  17 in total

Review 1.  How does the tumor microenvironment play a role in hepatobiliary tumors?

Authors:  Fathima Kamil; Julie H Rowe
Journal:  J Gastrointest Oncol       Date:  2018-02

2.  Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo.

Authors:  Rui Peng; Guang-Xi Zhao; Jing Li; Yu Zhang; Xi-Zhong Shen; Ji-Yao Wang; Jian-Yong Sun
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

3.  Establishment of experimental implantation tumor models of hepatocellular carcinoma in Wistar rats.

Authors:  Yi Jin; Dayue Tong; Junjie Shen; Jianyong Yang; Jiaping Li
Journal:  Tumour Biol       Date:  2014-06-07

4.  4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12.

Authors:  Marcelo M Rodríguez; Esteban Fiore; Juan Bayo; Catalina Atorrasagasti; Mariana García; Agostina Onorato; Luciana Domínguez; Mariana Malvicini; Guillermo Mazzolini
Journal:  Mol Ther       Date:  2018-09-18       Impact factor: 11.454

Review 5.  Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma.

Authors:  Francesco Dituri; Gianluigi Gigante; Rosanna Scialpi; Serena Mancarella; Isabel Fabregat; Gianluigi Giannelli
Journal:  Cancers (Basel)       Date:  2022-04-09       Impact factor: 6.575

6.  Prevention and Therapeutic Effects and Mechanisms of Tanshinone IIA Sodium Sulfonate on Acute Liver Injury Mice Model.

Authors:  Lunjie Lu; Jun Zhou; Jingying Zhang; Jun Che; Yang Jiao; Yusong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-04       Impact factor: 2.629

7.  DlgR2 knockdown boosts dendritic cell activity and inhibits hepatocellular carcinoma tumor in-situ growth.

Authors:  Zhen Lu; Yun-Hong Xia; Min Zhao; Bing Zhang; Wen-Ting Dai; Lu Ding; Li-Xia Hu; Jin-Ling Bi; Guo-Lin Jiang
Journal:  Oncotarget       Date:  2017-07-05

Review 8.  Protein dysregulation in graft versus host disease.

Authors:  Liren Qian; Delia Dima; Cristian Berce; Yu Liu; Ioana Rus; Lajos-Zsolt Raduly; Yi Liu; Bobe Petrushev; Ioana Berindan-Neagoe; Alexandru Irimie; Alina Tanase; Ancuta Jurj; Jianliang Shen; Ciprian Tomuleasa
Journal:  Oncotarget       Date:  2017-12-15

9.  Antitumor Activity of the Chinese Medicine JC-001 Is Mediated by Immunomodulation in a Murine Model of Hepatocellular Carcinoma.

Authors:  Meng-Hsien Chuang; Jinghua Tsai Chang; Li-Jin Hsu; Ming-Shiou Jan; Fung-Jou Lu
Journal:  Integr Cancer Ther       Date:  2016-10-03       Impact factor: 3.279

10.  Tumor-specific hepatic stellate cells (tHSCs) induces DIgR2 expression in dendritic cells to inhibit T cells.

Authors:  Yun-Hong Xia; Zhen Lu; Min Zhao; Wen-Ting Dai; Lu Ding; Li-Xia Hu; Guo-Lin Jiang
Journal:  Oncotarget       Date:  2017-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.